37 it-communication-"https:"-"https:" "https:" Postdoctoral positions at Northeastern University
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
About the Opportunity This job description is intended to describe the general nature and level of work being performed by people assigned to this classification. It is not intended to be construed
-
About the Opportunity This job description is intended to describe the general nature and level of work being performed by people assigned to this classification. It is not intended to be construed
-
cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical
-
fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical
-
approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also
-
About the Opportunity This job description is intended to describe the general nature and level of work being performed by people assigned to this classification. It is not intended to be construed
-
initiatives. Professional Development & Leadership: Participate in academic seminars, research, teaching, conferences, and internal presentations while developing leadership, communication, and project
-
exhibitor Qualifications • Doctor of Pharmacy degree from an ACPE-accredited institution • Eligible for pharmacist licensure in the State of Massachusetts • Excellent oral and written communication
-
diseases and conditions. The company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and
-
company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas